A novel germ-line mutation in p53 gene
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 1
Abstract
Germline mutations of p53 gene are rare, worldwide there are reported about 283 of such changes. They are strongly connected with Li-Fraumeni and Li-Fraumeni Like syndromes. They also may appear in multicancer syndrome. The aim of this study was to establish frequency of p53 mutations in multicancer families in polish population. DNA was extracted from patient’s peripheral blood samples. Mutations were analyzed employing the PCR-SSCP method with 7 pairs of radioactive primers, which covered exons 2-11. DNA fragments showing a different migration pattern were sequenced. In one case we found a change in exon 11 of p53 gene. A mutation was identified as adenosine insertion in codon 385 which caused an alteration of amino acids from 385 to 389. The STOP codon appeared in position 390 causing shorter p53 protein. This mutation was found in one of 38 cases and frequency of this mutation was establish on 2.6%. Insertion A in codon 385 did not appear in p53 mutational database IARC. Moreover, no mutations in exon 11 were reported in this database. Based on the family interview with the carrier we concluded that insertion A in exon 11 was not involved in cancer phenotype.
Authors and Affiliations
Wojciech Roesler, Anna Przybyła, Andrzej Mackiewicz, Katarzyna Lamperska
Epidemiology of lung cancer in the period from 1993 to 2002 in Konin and Piła, cities with discrete industrial-geographic structure
Introduction: Bad prognosis and permanent increase in the number of cases makes lung cancer the biggest problem of contemporary oncology. Scientific investigations prove that cigarette smoking is responsible for 80% of a...
Jedzenie owoców i warzyw a ryzyko raka piersi
Wstęp: Rak piersi stanowi światowy problem zdrowotny kobiet w każdym wieku. Choroba ta zajmuje drugie miejsce wśród przyczyn zgonów kobiet z powodu nowotworów złośliwych. Wyniki większości badań epidemiologicznych...
Zalecenia diagnostyczno-terapeutyczne dla wybranych nowotworów głowy i szyi. Rak szczęki i rak kompleksu nosowo-sitowego
Treatment of bone metastases in breast cancer patients
Bone metastases are a major problem in the clinical management of patients with breast cancer. With prolongation of survival, the challenge is to improve the quality of the patient’s remaining life. The treatment of me...
SCC-Ag, CYFRA 21-1 oraz wybrane wskaźniki laboratoryjne w monitorowaniu leczenia chorych na raka szyjki macicy
Cel: Podjęto próbę określenia użyteczności oznaczeń SCC-Ag oraz CYFRA 21-1, a także wyliczanego na podstawie oznaczeń stężenia kwaśnej alfa-1 glikopoteiny i prealbuminy surowiczego wskaźnika nowotworowego (CSI) w monit...